<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
72606-026-02
</NDCCode>
<PackageDescription>
1 VIAL, SINGLE-USE in 1 CARTON (72606-026-02) / .05 mL in 1 VIAL, SINGLE-USE
</PackageDescription>
<NDC11Code>
72606-0026-02
</NDC11Code>
<ProductNDC>
72606-026
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Eydenzelt
</ProprietaryName>
<ProprietaryNameSuffix>
Boav
</ProprietaryNameSuffix>
<NonProprietaryName>
Aflibercept
</NonProprietaryName>
<DosageFormName>
INJECTION
</DosageFormName>
<RouteName>
INTRAVITREAL
</RouteName>
<StartMarketingDate>
20240926
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
BLA
</MarketingCategoryName>
<ApplicationNumber>
BLA761377
</ApplicationNumber>
<LabelerName>
CELLTRION USA, Inc.
</LabelerName>
<SubstanceName>
AFLIBERCEPT
</SubstanceName>
<StrengthNumber>
2
</StrengthNumber>
<StrengthUnit>
mg/.05mL
</StrengthUnit>
<Pharm_Classes>
Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2025-11-12
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20240926
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>